SFMBT2 and prostate carcinoma: Moreover, we found that tail vein or intraprostatic injection of SFMBT2 knockdown LNCaP cells significantly induces metastasis, indicating that SFMBT2 acts as a metastasis suppressor in prostate cancer in vivo.